PureTech Health
PRTC17.4200.00% ( 0.000 )
PureTech Health (PRTC)
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. It is developing LYT-1...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 17.420
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- 19.920
- Volume Ratio
- 0.00
- Turnover Ratio
- --
PureTech Health Analyst Rating
View MoreForecast & Rating
Nov 3, 2025Price forecast
$46.00164.06%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- London Stock Exchange · Jul 17 at 11:00 AM
REG - PureTech Health PLC - PDMR Notification RSU Vesting
- Tip Ranks · Jul 13 at 07:26 PM
Peel Hunt Reaffirms Their Buy Rating on PureTech Health (PRTC)
- MorningStar · Jul 13 at 01:17 AM
PureTech Founded Entity Celea Therapeutics Doses First Patient in Global Phase 3 SURPASS-IPF Trial Evaluating Deupirfenidone for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
- biopharmadive · Jul 6 at 07:57 PM
A PureTech startup banks $180M for a new IPF drug
- London Stock Exchange · Jun 10 at 11:38 AM
REG - PureTech Health PLC - Result of AGM
- Market Beat · May 5 at 07:20 PM
PureTech Health (LON:PRTC) Shares Down 9.2% - Time to Sell?
